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Abstract 
Background: Hidradenitis suppurativa (HS) is a chronic, relapsing inflammatory disease of 
skin, characterized by recurrent draining sinuses and abscesses, predominantly in skin folds 
carrying terminal hairs and apocrine glands. 
Method: This study reviewed 54 sites in 27 patients with moderate to extensive chronic 
inflammatory skin lesions treated surgically in our hospital from 2004 through 2009, with a 
follow-up of at least 6 months. 
Result: A total number of 54 operative procedures were performed during the study period 
with 42% (23 sites) involving the axilla, 20% (11 sites) involving the gluteal area, %24 (13 sites) 
involving the perineal area and 12% (7 sites) involving the inguinal region. 
Conclusion: Conservative treatment methods have little or no effects especially on gluteal, 
perineal/perianal, axillary hidradenitis suppurativa. The morbidity associated with the estab-
lished form of this disease is significant, and the only successful treatment is wide surgical 
excision. 
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Introduction 
Hidradenitis suppurativa (HS) is a chronic, re-
lapsing inflammatory disease of skin, characterized 
by recurrent draining sinuses and abscesses, predo-
minantly in skin folds carrying terminal hairs and 
apocrine glands.1 The incidence may be as high as one 
in 300.2 
Hidradenitis suppurativa (from the Greek hi-
dros, sweat and aden, glands), also known as acne 
inversa, was first described by Velpeau, a French 
physician in 1839, who reported a peculiar inflamma-
tion of the skin with the formation of superficial ab-
scesses in the axillary, mammary and perianal areas.3 
In 1854, this condition was termed ‘hidrosade´nite 
phlegmoneuse’ by Verneuil, a French surgeon who also 
suggested an association between HS and sweat 
glands, which had been described by Purkinje in 
1833.1 
Hidradenitis suppurative may affect any area of 
the body surface where apocrine glandular tissue is 
found, but most often it affects the skin of the axillae 
and inguinoperineal regions.2 
Although the pathophysiology is understood 
poorly, it generally is believed that obstruction of the 
apocrine and/or follicular pores results in glandular 
dilatation and bacterial superinfection with subse-
quent gland rupture disseminating infection 
throughout the subcutaneous tissue plane.3 Conse-
quently, hidradenitis is associated with chronic pain-
ful abscesses, multiple odiferous draining sinus tracts, 
and chronic fibrosis with range-limiting scar forma-
tion.4 Anogenital involvement most commonly affects 
the groins with extension to inguinal regions, mons 
pubis, inner thighs and sides of scrotum. The peri-
neum, buttocks and perianal folds are often included. Int. J. Med. Sci. 2010, 7 
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The sinuses can dissect deep into tissue, involving 
muscle, fascia and bowel forming a labyrinth of tracts 
in advanced cases.8 
However, as the abscesses extend deeper into the 
subcutaneous tissue, intercommunicating sinus tracts 
develop, resulting in irregular hypertrophic scars.6 
Rarely, the chronic inflammation results in malignant 
transformation to squamous cell carcinoma.10 In such 
a developed phase, antibiotics are usually ineffective 
alone and surgical treatment is required.4,9,14 
The exact etiology of HS still remains unclear, 
genetic factors may play a role as a positive family 
history has been elicited in 26% of patients with HS. 
The role of endocrine factors in the etiology of HS has 
been controversial.1 
There is no consensus about the relationship 
between HS and sex, race, and site of the lesions. 
Axillary location seems to be more frequent in wom-
en. The gluteal, inguinal, perineal, and perianal zones 
are more frequently involved in men. HS appears 
more commonly in young adults and is observed after 
puberty.3 
In women, the condition frequently flares pre-
menstrually and following pregnancy and it some-
times eases during pregnancy and after the meno-
pause; these observations incriminate sex hormones. 
Children are never affected unless they have preco-
cious puberty.8 
Although exogenous factors such as the use of 
deodorants and shaving are thought to be causal, they 
have not been shown to be significantly responsible in 
a retrospective comparison of 40 patients with HS.13 
Smoking is more common in patients with HS but the 
aetiological basis is unknown. From the exceedingly 
high rate of smokers among patients with this condi-
tion one may conclude that cigarette smoking is a 
major triggering factor of hidradenitis suppurativa.15 
Wiltz et al. reported an association between smoking 
and perianal HS in 70% of patients.1 Obesity is an ex-
acerbating factor, and weight loss can help control the 
disease severity.1,4 
Early-stage treatment consists primarily of topi-
cal (clindamycin) or systemic antibiotics (tetracyc-
lines, clindamycin, rifampicin), topical antiseptics and 
intralesional corticosteroids (triamcinolone aceto-
nide). Systemic retinoids (isotretinoin, etretinate) an-
tiandrogen therapy (cyproterone acetate, finasteride), 
immunotherapy (TNF alfa inhibitors), oral immuno-
suppressive agents (cyclosporin) have also shown a 
positive effect on disease progression.4,12 Radiothera-
py and laser treatment applied cases available on li-
terature.1 Currently available medical treatments are, 
however, insufficient and their efficacy is only tran-
sient. As a result, advanced-stage severe HS requires 
invasive surgical removal of all the involved tis-
sue.1,5,8,11 
In this report, we present our experience with 
moderate and extensive perineal, perianal, axillary 
and gluteal hidradenitis suppurativa cases, including 
our treatment methods and outcomes. 
 
Patients and Methods 
This study reviewed 54 sites in 27 patients with 
moderate to extensive chronic inflammatory skin le-
sions treated surgically in our hospital from 2004 
through 2009, with a follow-up of at least 6 months. 
Nineteen (%70) patients were men and eight patients 
were women. The mean age at the time of presenta-
tion for operative management was 41.2 years (range, 
24-58 y) and the average duration of symptomatic 
disease was 7.3 years (range, 0.9-30 y). None of these 
patients were detected to have any comorbid or asso-
ciated conditions. According to answers about clean-
ing habits; personal hygiene was poor in most of the 
patients. 18 of the 21 (85%) male patients and 3 of the 8 
(37%) female patients were smokers. 3 patients (2 fe-
male, 1 male) had insulin-dependent diabetes melli-
tus. (See Table 1) Most of the included patients had 
previously been prescribed a treatment by non sur-
gical or inadequate surgical treatment modalities such 
as short term antibiotic treatments, local wound care 
and abscess drainage for long periods (up to 20 years). 
Seven patients previously were treated by limited 
local excisions and primary closure. 
Total surgical excisions under general anaesthe-
sia were performed on all patients. All patients were 
operated on in the lithotomy, jackknife, supine or 
prone positions. Rectal tubes were used for preven-
tion of the surgical field from contamination with 
stool in the patients with perianal or gluteal lesions, 
colostomy was not used in any patients for this pur-
pose. The operative technique was based on the com-
plete excision of the entire diseased skin and subcu-
taneous fatty tissue and down to the muscular fascia 
on aggressive cases. Patients with limited disease in-
volving the axilla or inguinal region were selected for 
excision and primary closure if the skin and soft tissue 
could be mobilized adequately. The size of the defects 
created after excision of the lesions ranged from 15 
cm2 up to 1680 (42X40) cm2. Preoperative and post-
operative antibiotherapy is administered for all pa-
tients according to wound tissue culture tests results. 
Culture results were Proteus Mirabilis, Staphylococ-
cus Aureus and E. Coli predominantly, and were 
sensitive to Ciprofloxacin and Seftazidim antibiotic 
protocol mostly. Int. J. Med. Sci. 2010, 7 
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Table 1. Patient characteristics. 
Patient 
No. 
Sex Age Smoking,p/y Site Defect  Size,cm  Duration 
of ill-
ness/y 
Surgical Method  Follow-up,mo Recurrence 
1 M  50  -  Gluteal    10X15  5  Skin grafting  11 - 
2 F  42  -  Axilla    8X12  0.9  Parascapular fasciacutaneous 
flap 
33 - 
3 M  39  0.5/20  Inguinal  3X10  3  Local fasciacutaneous flap  15  + 
4  M  47  1/30  Bilateral Axilla   8X3,6X4  2  Primary closure  48 - 
5 F  24  -  Axilla    3X5  1  Primary closure  10 - 
6 M  38  1/12  Gluteal    9X13  1.5  Skin grafting  17 - 
7  M  49  1.5/22  Gluteal    14X11  6  Skin grafting  16 - 
8 M  56  1/30  Gluteal  14x12  20  Skin grafting  24 - 
       Bilateral  İnguinal  3X15, 4X10    Primary closure   -  
       Bilateral  Perineal  20X20,18X20    Skin grafting   -  
9 M  47  1/23  Gluteal,perianal  30X20  3  Skin grafting  36 - 
       Perineal   5X15    Primary closure   -  
10 F  57  -  Gluteal,perianal  42X40  30  Skin grafting  40 - 
       Bilateral  Perineal  20X20,15X20 
 
  Skin grafting    -  
       Bilateral  axilla  18X10,15X12    Primary closure     
11 F  55  -  Bilateral  Peri-
neal, 
15X10   2  Primary closure  36 - 
       Bilateral  İnguinal 
 
 9X12 
  
  Primary closure   -  
       Bilateral  Axilla 
 
3X5 
 
  Primary closure     
12 M  51  2/25  Gluteal,perianal  21X38  12  Skin grafting  21 - 
13 M  24  1/5  Axilla  3X10  3  Primary closure  6 - 
14 M  24  -  Bilateral  Axilla  20X15,15X15  6  Parascapular fasciacutaneous 
 
12 - 
15 M  32  2/10  Axilla 
 
10X10,  
 
4  Parascapular fasciacutaneous  20  - 
 
       İnguinal 
 
 2X10 
 
  Primary closure     
- 
       Perineal 10X18    Gracilis musculocutaneous flap    - 
16 M  42  1/20  Axilla  12X12  16  Parascapular fasciacutaneous 
flap 
18 - 
17 M  39  1/15  Axilla 
 
5x8 
 
4  Primary closure  10 - 
       Gluteal  16X20    Skin grafting   -  
       Perineal 2X8    Primary closure   -  
18 F  45  -  Axilla  10X5  5  Parascapular fasciacutaneous 
flap 
 
20 - 
19 M  58  1/30  Gluteal,perianal  15X20  20  Fasciacutaneous V-Y advance-
ment 
10 - 
20 M  40  2/20  Gluteal,perianal 
 
20X42 
 
7  Skin grafting  
 
48 - 
       Perineal 15x12    Fasciacutaneous flap   -  
21 M  45  3/22  Bilateral  axilla  15X8,15x10  12  Parascapular fasciacutaneous 
flap  
20 - 
22 M  55  1/30  Gluteal  10X12  7  Local transposition flap  8 - 
23 F  30  1/12 Axilla  3X9  15  Primary closure  16 - 
       İnguinal 4X10    Primary closure   -  
24 F  32  0.5/5  Bilateral  axilla  4X8,3X8  8  Primary closure  9 - 
25 M  45  1/22  Bilateral  axilla 
 
3X7,12X6 
 
5  Parascapular fasciacutaneous 
flap 
7 - 
       Bilateral  perineal  20X10,8X15    Fasciacutaneous flap   +  
26 M  24  -  Perineal  4x5  2  Primary closure  12 - 
27 F  25  -  Axilla  3X7  3  Primary closure  10 - 
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Patient reports 
Patient 8 
A 56-year old male patient had recurrent and 
progressive lesions on his perineal, inguinal, perianal 
and gluteal regions for 20 years. Drainage, local 
wound care and antibiotherapy was used previously 
every time the lesions were exacerbated. Perineal le-
sions also affected the scrotal skin. (See Figure 1) The 
lesions were excised widely and the scrotal skin down 
to the dartos fascia anal sphincter was preserved. The 
Inguinal defect was closed primarily and the perineal 
lesions were reconstructed by split thickness skin 
grafts. Gluteal lesions were excised and skin grafted 8 
months later at a second stage.  
 
 
 
      
Figure 1: Patient 8 (56 years). (A) Preoperative view: 
Preineal area with putrid productive infection. (B) Post-
operative result after 1 year, no scar contracture, no re-
currence. 
 
Patient 10 
57-year old female patient. 30 years ago a lesion 
was excised from the coccygeal region but recurred 10 
years later and treatment with retinoids was started. 
However the lesions relapsed and disseminated to a 
wide area over time (Figure 2). The lesions of this pa-
tient were very extensive and drastic which are rare in 
the literature and especially the effects of the disease 
on the perineal area was dramatic. Both gluteal areas, 
perianal, perineal, inguinal and axillary regions were 
affected. The lesion on right labia majora was en-
larged to 10x15 cm and left labia majora was 10x20 
cm. Surgical treatment was performed in 3 stages. At 
the first stage all perineal and gluteal lesions were 
excised with at least 1 cm margins. The size of the 
excised material from the gluteal region was 42x40 
cm. Split thickness skin grafts from the thigh were 
used for reconstruction. Excision and primary closure 
of the axillary lesions were done in second and third 
stages. We obtained excellent functional results (con-
venience during urination etc.) and moderate cos-
metic results. 
 
 
 
 
    
 
    
 
 
Figure 2: Patient 10. A 57–year-old female patient with 
very severe widespread Hidradenitis suppurativa. (A,B) 
Preoperative view of inguinal,perineal and gluteal areas. 
(C,D) Postoperative results after 6 month. (E) View of 
postoperative 3 year. 
 
 
 
 
Patient 14 
24-year old male patient had bilateral axillary 
hidradenitis suppurativa for the last 6 years. Both 
axillae were treated in the same stage. Excised area 
was 20x15 cm on the right side and 15x15 cm on the 
left side. Thoracodorsal perforator based fasciocuta-
neous flaps were used for reconstruction. (See Figure 
3). 
 Int. J. Med. Sci. 2010, 7 
 
http://www.medsci.org 
244
 
 
 
 
 
 
 
Figure 3. Patient 14. A 24-year-old male. (A,B) Preo-
perative view of axillary region. (C,D) The axillary defect is 
covered with toracodorsal perforator based fasciocuta-
neous flaps. (Intraoperative view) 
 
 
 
Patient 19 
58-year old male patient had draining lesions in 
his intergluteal and perianal regions for the last 20 
years. Abscess drainage was performed at least 3-4 
times every year and he had frequent use of various 
oral antibiotics. We performed total excision of a 
15x20 cm lesion with 1 cm surgical margins down to 
the muscle fascia. The external anal sphincter was 
protected. A right sided gluteal V-Y advancement flap 
was used for the closure of the defect. (Figure 4) 
 
 
 
Figure 4. Patient 19. A 58-year-old male patient with 
severe hidradenitis suppurativa of the gluteal and perianal 
area. (A) Preoperative view with fistulas in intergluteal 
area.(B) After excision of the inflammatory region and 
closed with V-Y advancement fasciacutaneous flap. 
 
Results 
A total number of 54 operative procedures were 
performed during the study period with 42,6% (23 
sites) involving the axilla, 20,3% (11 sites) involving 
the gluteal area, %24,2 (13 sites) involving the perineal 
area and 12,9% (7 sites) involving the inguinal region. 
Hurley’s clinical staging was used for the classifica-
tion of patients (Table 2). Excision and primary clo-
sure was used only for mild and moderate (Hurley 
stage I) axillary and inguinal disease, whereas wide 
local excision and split-thickness skin grafting or fas-
ciocutaneous flap was the mainstay of treatment in 
patients with diffuse disease (Hurley stage II and III). 
 
Table 2. Hurley Staging System. 
Stage   Characteristics 
I  Solitary or multiple isolated abscess formation without 
scarring or sinus tracts. 
II  Recurrent abscesses, single or multiple widely separated 
lesions, with sinus tract formation. 
III  Diffuse or broad involvement across a regional area with 
multiple interconnected sinus tracts and abscesses.  
 
Surgical margins were at least 0.5-1 cm in the 
axillary region and 1-1.5 cm in the gluteal region and 
down to the muscle fascia. Affected labia majora and 
scrotal skin was also excised widely. In the perianal 
region lesions were excised by protecting the external 
anal sphincter and none of the patients required en-
doanal excision, Colostomy was not performed for 
any patient.  
Treatment was performed in 2 stages in three 
patients and 3 stages in one patient. For the recon-
struction of the glutal region Split thickness skin graft 
(STSG) was used in 9 patients (Figure 5,6), fasciocu-
taneous V-Y advancement flap in one patient and 
transposition flap in 1 patient. Primary closure was Int. J. Med. Sci. 2010, 7 
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used in 13 axillary regions and 10 fasciocutaneous 
flaps from the parascapular region were used. 4 flaps 
were thoracodorsal perforator based. In 2 patients 
with bilateral axillary disease, bilateral excision and 
toracodorsal perforator based flap reconstructions 
were performed at a single stage. To preserve the 
shoulder movements and to prevent contactures, skin 
grafts were not used for the reconstruction of the wide 
axillary defects. Five of the perineal defects were 
closed primarily, 4 were by skin grafting, 3 by fasci-
ocutanous transposition flaps and one perineal defect 
was closed by gracilis myocutaneous flap. Inguinal 
region reconstruction was done by primary closure in 
6 patients, and fasciocutaneous transposition flap was 
used for 1 patient.  
 
 
 
 
 
 
Figure 5. Patient 9. A 47-year-old male (A,B) Gluteal and 
perianal region before treatment, showing multiple con-
fluent suppurative and inflammatory nodules. Extraordinary 
widespread of HS in the right gluteal area. (C) Excision 
material of lesion. (D) View of defect after excision. 
 
 
 
 
 
 
 
Figure 6. Patient 12. A 51-year-old male patient with 
spread and severe gluteal and perianal HS. (A) Preoperative 
view with multiple fistulas in the gluteal area.(B) After ex-
cision of the inflamatory region. (C) View of excision ma-
terial. (D) Postoperatif result after 6 month. 
 
The duration time of hospitalization was related 
with the extent and severity of the lesions and the 
mean hospitalization was 6 days (3-41days). All pa-
tients were followed with daily dressing changes. All 
flaps survived totally except for minor distal marginal 
flap necrosis in 2 parascapular flaps which were 
treated by simple suturation. 
Early postoperative rehabilitatiton to preserve 
shoulder motility was started in all patients with 
axillary disease. Skin grafts were succesful generally, 
minor graft loss areas were treated by local wound 
care, and none of the patients required additional 
grafting.  Only 2 recurrences were observed in this 
patient series. Both were inguinal lesions treated by 
primary closure. The recurrences were treated by 
wide excision and defect closure by fasciocutaneous 
flaps.  Int. J. Med. Sci. 2010, 7 
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Patients have been followed for a mean of 19.7 
months (range 6-48 mo). Some patients who under-
went HS surgery were not willing come to clinic for 
checking up previous operated areas if they have no 
problem. Developing HS on the new areas gave 
chance to us for long term follow up on these patients. 
Discussion 
HS remains a challenging disease for both the 
patient and the physician. It is a chronic debilitating 
disease whose aetiology is still controversial.1 
Because HS rarely is seen before puberty or after 
menopause, and recurrence of acute disease has ap-
peared after hormone administration, several inves-
tigators have suggested that the condition may be 
caused by an endocrine abnormality or, more specif-
ically, may be androgen dependent.4,5 
Because of the varying clinical manifestations 
and sites involved by the disease, patients with HS 
present to, or are referred to many different special-
ties, including gynecology, surgery, medicine, der-
matology, plastic surgery, immunology and infection 
control. Unfortunately, HS is commonly mismanaged 
owing to a failure of early diagnosis and once estab-
lished, chronicity and progression ensue. No specific 
test for diagnosis exists. Inflammatory abscess-like 
swelling(s) in apocrine gland bearing skin should be 
regarded as possible HS.  
The clinician should also bear in mind the other 
possible sites of HS, which may have no or little apo-
crine component. In order of frequency of involve-
ment, the following sites are recognized: axillaries, 
inguinal, perianal and perineal, mammary and 
inframammary regions, buttock, pubic region, chest, 
scalp, retroauricular, and eyelid skin.5 
Conservative treatment and incision and/or 
surgical removal of the abscesses and fistulas are 
usually futile.1,14 The success of medical therapies, 
however, often is limited because of the indolent and 
recurrent nature of the disease. Operative excision of 
the involved follicles and inflammatory process is the 
only curative treatment.4,6 
Various surgical methods for the treatment of 
hidradenitis suppurativa have been described pre-
viously. Wide local excision with skin grafting, skin 
flap transfer, and primary closure has been common. 
However, with the popularization of surgical me-
thods using fasciocutaneous or musculocutaneous 
flaps in the field of plastic surgery, these flaps have 
been applied positively for the treatment of Hidrade-
nitis suppurativa.6  
In this study we are presenting a case series in-
cludes with extensive and severe hidradenitis sup-
purativa in which some cases are very rare in litera-
ture (patient 10). We believe that excision with wide 
margins and adequate depth and reconstruction with 
appropriate methods leads to good results in control-
ling the disease and preventing the recurrences.  
Our observations from this group of patients is 
that lack of personal hygiene and utilization of in-
adequate treatment modalities result in severe and 
widely disseminated lesions that affects the quality of 
life and general health status of the patients. 
Although skin grafts may result in contractures 
and extensive scarring, this can be acceptable espe-
cially in the gluteal regions. In this area, skin graft 
contraction does not cause functional problems and 
scars are covered easily. Patients generally do not 
complain about aesthetic results. Reconstruction of 
the defects with flaps may prevent contractures and 
bad scarring but local flaps might posses the risk of 
carrying the same affected skin and lead to recur-
rences. Hence local or regional flaps can only be used 
if a wide and adequate excision with sure margins is 
performed. We used only two flaps in 11 severe HS 
cases with gluteal lesions. Primary closure was used 
for mild and moderate (Hurley stage I) HS defects in 
axillary, inguinal, and perineal regions after wide 
excision of the diseased areas and elevation and ad-
vancement of the skin flaps. Primary closure is pri-
marily preferred by non-plastic surgeons and inade-
quate limited excision leads to recurrences and dis-
semination of the disease to wider areas.  
Perianal lesions are especially difficult to treat. 
Despite its relatively common occurrence, perianal 
hidradenitis suppurativa is infrequently diagnosed 
correctly and recurs in many patients despite appro-
priate surgical treatment, making the disease a source 
of frustration for surgeon and patient alike.16 Preser-
vation of the anal sphincter is important. If endoanal 
lesions are present, a colostomy might be required to 
perform adequate excision of such lesions. None of 
the patients in this series had such lesions, and there-
fore colostomy was not needed. 
In this study, 10 parascapular fasciocutaneous 
flaps and, 13 primary closures were performed in the 
axillary region. Preserving shoulder movement and 
preventing the formation of contractures are impor-
tant in the axillary region.7,9  The goals of surgical 
management are to completely excise all the involved 
tissue, preserve function, avoiding development of 
axillary contracture and obtain satisfactory aesthetic 
results.7 Therefore, skin grafts were not used for the 
reconstruction of the axillary of fasciocutaneous flaps 
from the parascapular region allows a thin and pliable 
reconstruction that is suitable for axillary repair. 
Thoracodorsal perforator flaps were used in espe-
cially wide defects. Int. J. Med. Sci. 2010, 7 
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Conclusion 
 Hidradenitis suppurativa is a disease which has 
many different treatment modalities. Surgical options 
have wide variabilities according to affected areas. We 
believe that it is very important to choose appropriate 
surgical operation to diseased area to avoid contrac-
tures, recurrens and bad aesthetic results. We have 
not noted any scar contracture preventing functional 
movements in our patients. All patients were very 
satisfied with the aesthetic result.  
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